Finance

Lists
4521:TYO
Kaken Pharmaceutical Co Ltd
3 705,00 JPY
-0,94%
(-35,00) 1D
9 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4521...
Open
3 755 JPY
High
3 755 JPY
Low
3 700 JPY
Mkt. cap
163,54 მლრ.
Avg. vol.
108,27 ათ.
Volume
166,90 ათ.
Dividend
5,13%
Quarterly dividend
48 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
13,61
52-wk high
4 445 JPY
52-wk low
3 540 JPY
EPS
272 JPY
Shares outstanding
39,72 მლნ.
No. of employees
1 ათ.
Open
3 755 JPY
High
3 755 JPY
Low
3 700 JPY
Mkt. cap
163,54 მლრ.
Avg. vol.
108,27 ათ.
Volume
166,90 ათ.
Dividend
5,13%
Quarterly dividend
48 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
13,61
52-wk high
4 445 JPY
52-wk low
3 540 JPY
EPS
272 JPY
Shares outstanding
39,72 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
About Kaken Pharmaceutical Co Ltd
CEO-
Employees1,11 ათ.
Founded1917
Headquarters-
SectorPharmaceutical industry
Websitekaken.co.jp
Last report
7 აგვ. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
30,16 მლრდ. / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
20,49 მლრდ.
18,26 მლრდ.
19,25 მლრდ.
30,16 მლრდ.
Cost of goods sold
8,78 მლრდ.
9,01 მლრდ.
10,09 მლრდ.
9,18 მლრდ.
Cost of revenue
8,78 მლრდ.
9,01 მლრდ.
10,09 მლრდ.
9,18 მლრდ.
Research and development expenses
6,29 მლრდ.
3,97 მლრდ.
4,94 მლრდ.
4,60 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,23 მლრდ.
4,92 მლრდ.
4,92 მლრდ.
5,47 მლრდ.
Operating expense
11,52 მლრდ.
8,90 მლრდ.
10,62 მლრდ.
10,07 მლრდ.
Total operating expenses
20,30 მლრდ.
17,91 მლრდ.
20,71 მლრდ.
19,25 მლრდ.
Operating income
187,00 მლნ.
354,00 მლნ.
-1,46 მლრდ.
10,90 მლრდ.
Other non operating income
-27,00 მლნ.
34,00 მლნ.
43,00 მლნ.
8,00 მლნ.
EBT including unusual items
988,00 მლნ.
588,00 მლნ.
328,00 მლნ.
11,24 მლრდ.
EBT excluding unusual items
184,00 მლნ.
598,00 მლნ.
-1,41 მლრდ.
11,26 მლრდ.
Income tax expense
267,00 მლნ.
182,00 მლნ.
-418,00 მლნ.
2,80 მლრდ.
Effective tax rate
27,02%
-
-127,44%
24,93%
Other operating expenses
-
-
-
-
Net income
721,00 მლნ.
406,00 მლნ.
746,00 მლნ.
8,44 მლრდ.
Net profit margin
3,52%
-
3,87%
27,99%
Earnings per share
-
-
-
-
Interest and investment income
78,00 მლნ.
324,00 მლნ.
91,00 მლნ.
393,00 მლნ.
Interest expense
-11,00 მლნ.
-11,00 მლნ.
-13,00 მლნ.
-14,00 მლნ.
Net interest expenses
67,00 მლნ.
313,00 მლნ.
78,00 მლნ.
379,00 მლნ.
Depreciation and amortization charges
-
-
752,00 მლნ.
-
EBITDA
922,00 მლნ.
992,50 მლნ.
-624,75 მლნ.
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები